These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7341286)

  • 1. Proceedings of the Joint ESACT -- IABS meeting on the use of heteroploid and other cell substrates for the production of biologicals. Heidelberg (F.R. Germany) 18-22 May, 1981.
    Dev Biol Stand; 1981; 50():1-398. PubMed ID: 7341286
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of the Joint ESACT/IABS Meeting on the production and exploitation of existing and new animal cell substrates. Gardone Riviera, Italy, 21-25 May 1984.
    Dev Biol Stand; 1985; 60():1-540. PubMed ID: 3899778
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous cell lines as substrates for biologicals: report of a joint meeting of WHO, IABS (cell Culture Committee Subsection), and ESACT.
    Spier RE
    Mol Biother; 1988; 1(2):114-5. PubMed ID: 3269249
    [No Abstract]   [Full Text] [Related]  

  • 4. Symposium on Continuous Cell Lines as Substrates for Biologicals. Arlington, Virginia, USA (Washington, D.C.), May 26-29, 1988. Proceedings.
    Dev Biol Stand; 1989; 70():1-304. PubMed ID: 2759343
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production.
    Griffiths E
    Dev Biol Stand; 1999; 98():153-7; discussion 167. PubMed ID: 10494968
    [No Abstract]   [Full Text] [Related]  

  • 7. WHO Expert Committee On Biological Standardization.
    World Health Organ Tech Rep Ser; 1998; 878():i-vi, 1-101. PubMed ID: 9731464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances No 50).
    Dev Biol Stand; 1998; 93():141-71. PubMed ID: 9737395
    [No Abstract]   [Full Text] [Related]  

  • 9. Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals.
    World Health Organ Tech Rep Ser; 1987; 747():1-29. PubMed ID: 3107222
    [No Abstract]   [Full Text] [Related]  

  • 10. A critical view of cell substrates with regard to cell transformation and cancer.
    Horodniceanu F
    Dev Biol Stand; 1981; 50():47-57. PubMed ID: 7341298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: On shipping biologicals.
    Acker RF
    Fed Proc; 1975 Jun; 34(7):1533-4. PubMed ID: 1132519
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell substrates. Their use in the production of vaccines and other biologicals. Past achievements - future expectations.
    Meyer HM
    Adv Exp Med Biol; 1979; 118():1-5. PubMed ID: 495259
    [No Abstract]   [Full Text] [Related]  

  • 13. WHO activities towards the three Rs in the development and control of biological products.
    Milstien J; Grachev V; Padilla A; Griffiths E
    Dev Biol Stand; 1996; 86():31-9. PubMed ID: 8785961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry perspective for biotech products.
    Möritz A
    Dev Biol (Basel); 2004; 118():37-44. PubMed ID: 15645671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICH guidelines and PhEur monographs on derivation and characterisation of cell substrates used for production of biotechnological/biological products. International Conference on Harmonisation.
    Dobbelaer R
    Dev Biol Stand; 1999; 98():159-65; discussion 167. PubMed ID: 10494969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologicals: an attempt at classification and its implication for the viral safety of products.
    Horaud F
    Dev Biol Stand; 1993; 81():17-24. PubMed ID: 8174800
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell substrates. Their use in the production of vaccines and other biologicals. Benefit-risk assessment.
    Dull HB
    Adv Exp Med Biol; 1979; 118():187-93. PubMed ID: 495265
    [No Abstract]   [Full Text] [Related]  

  • 18. Covalent modifications of antitetanus F(ab')2 fragments with natural and synthetic polyamines and their effects on the antibody endocytosis in cultured HL60 cells.
    Hervé F; Ghinea N; D'Athis P; Carrupt PA; Scherrmann JM
    Bioconjug Chem; 2008 Aug; 19(8):1543-55. PubMed ID: 18630939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell substrates. Their use in the production of vaccines and other biologicals.
    Adv Exp Med Biol; 1979; 118():1-220. PubMed ID: 40404
    [No Abstract]   [Full Text] [Related]  

  • 20. Testing human biologicals in animal host resistance models.
    Burleson GR; Burleson FG
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.